logo

For the Inventor, By the Inventor

Baltimore, MD, United States of America

Edythe D London

This inventor holds 4 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, Johns Hopkins University, The United States of America, Represented by the Secretary, Department. Active years: 1993-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edythe D London. Retrieved from https://idiyas.com/inventor/edythe-d-london

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 149(Granted Patents)


Company Filing History:

goldMedal2 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
silverMedal1 out of 3,801 
 
Johns Hopkins University
 patents
bronzeMedal1 out of 1 
 
The United States of America, Represented by the Secretary, Department
 patent
4. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1993-1999

Loading Chart...
4 patents (USPTO):Explore Patents
1. 5969144 - Radiolabeled pyridyl-7-azabicyclo[2,2,1]heptanes (1999-10-19),
2. 5726189 - Method for imaging nicotinic acetylcholinergic receptors in the brain (1998-03-10),
3. 5266594 - Inhibitors of nitric oxide synthase and use thereof to prevent glutamate (1993-11-30),
4. 5225440 - Attenuation of the opioid withdrawal syndrome by inhibitors of nitric (1993-07-06),

Title: Edythe D London: Innovator in Radiolabeled Compounds

Introduction

Edythe D London is a prominent inventor based in Baltimore, MD (US). She has made significant contributions to the field of radiolabeled compounds, particularly in the study of nicotinic cholinergic receptors. With a total of 4 patents, her work has implications for both research and clinical applications.

Latest Patents

Edythe's latest patents include innovative methods for imaging nicotinic acetylcholinergic receptors in the brain. One of her notable inventions is directed to radiolabeled pyridyl-7-azabicyclo[2,2,1]heptanes. This invention focuses on radiolabeled epibatidine analogues, specifically FPH labeled with radioisotopes of fluorine and/or carbon. These compounds are utilized to noninvasively image and quantify nicotinic cholinergic receptors in the living brain, aiding in research studies and the diagnosis of neurodegenerative diseases.

Career Highlights

Throughout her career, Edythe has worked with the United States of America as represented by the Department of Health. Her expertise in radiolabeled compounds has positioned her as a key figure in her field.

Collaborations

Edythe has collaborated with notable individuals such as Alane S Kimes and Andrew Horti. These partnerships have contributed to her innovative work and advancements in the study of brain receptors.

Conclusion

Edythe D London is a trailblazer in the field of radiolabeled compounds, with a focus on imaging techniques that enhance our understanding of neurodegenerative diseases. Her contributions continue to impact both research and clinical practices.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…